My dad passed away from prostate cancer at 55 in 2004 so I started researching treatments. I am from the NW and was a true Dendreonite during the late 2000's, and so was focused on immunotherapy companies. I fared financially much better than Dendreon the company by selling most shares near high, and have had highs and lows investing in immunotherapies since. Never completely gave up on NWBO but really started averaging down heavily in the past year.
News 
Market Data 
Discover 
